Ocata Therapeutics Inc Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

10/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
25/11/15	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	03/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARGENX SE	-0.41%	+5.35%	+77.59%	+135.19%	59.1B
WUXI APPTEC CO., LTD.	+2.32%	+5.03%	+75.26%	+92.31%	55.19B
BIONTECH SE	+3.86%	+6.93%	-11.32%	-10.57%	24.67B
INSMED INCORPORATED	+4.30%	+7.95%	+14.11%	+440.44%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	+0.64%	+7.14%	+50.90%	-1.05%	19.69B
GENMAB A/S	-1.45%	+7.33%	+41.02%	-28.95%	17.56B
PHARMAESSENTIA CORPORATION	0.00%	+20.78%	+186.15%	+347.42%	16.22B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+4.91%	+20.18%	+48.55%	-	14.84B
EXELIXIS, INC.	+3.50%	+1.97%	+21.02%	+193.33%	14.04B
Average	+1.97%	+8.57%	+55.92%	+146.02%	27.28B
Weighted average by Cap.	+1.68%	+6.47%	+59.30%	+135.69%

Employees

Sector